telmisartan has been researched along with Pulmonary Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, WW; Li, H; Liu, BC; Lu, W; Sun, W; Wang, DL; Wang, PJ; Yu, CP; Zhang, N | 1 |
| Chen, Y; Fan, Z; Liu, H | 1 |
| Hara, Y; Harada, T; Kikuzuki, R; Okada, M; Yamawaki, H | 1 |
1 review(s) available for telmisartan and Pulmonary Hypertension
| Article | Year |
|---|---|
Calcium channel blockers for pulmonary arterial hypertension.
Topics: Aged; Benzimidazoles; Benzoates; Calcium Channel Blockers; Humans; Hypertension, Pulmonary; Middle Aged; Nifedipine; Randomized Controlled Trials as Topic; Telmisartan | 2015 |
2 other study(ies) available for telmisartan and Pulmonary Hypertension
| Article | Year |
|---|---|
Telmisartan attenuates monocrotaline-induced pulmonary artery endothelial dysfunction through a PPAR gamma-dependent PI3K/Akt/eNOS pathway.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Disease Models, Animal; Endothelium, Vascular; Hypertension, Pulmonary; Male; Monocrotaline; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphorylation; PPAR gamma; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Signal Transduction; Telmisartan | 2014 |
Effects of telmisartan on right ventricular remodeling induced by monocrotaline in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Body Weight; Echocardiography; Fibrosis; Histocytochemistry; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Monocrotaline; Myocardium; Organ Size; Rats; Rats, Wistar; Stroke Volume; Systole; Telmisartan; Transforming Growth Factor beta1; Ventricular Remodeling | 2009 |